Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2
The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has infected millions of individuals and continues to be a major health concern worldwide. While reverse transcription-polymerase chain reaction remains a reliable method for detecting infections, limitations of this technology, particul...
Main Authors: | Charles P. Neff, Mile Cikara, Brian J. Geiss, G. Thomas Caltagirone, Albert Liao, Shaikh M. Atif, Bradley Macdonald, Richard Schaden |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Current Research in Biotechnology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259026282300014X |
Similar Items
-
Inhibition of SARS-CoV-2 replication by a ssDNA aptamer targeting the nucleocapsid protein
by: Yanping Huang, et al.
Published: (2024-04-01) -
DNA origami-enhanced binding of aptamers to Staphylococcus aureus cells
by: Yasaman Ahmadi, et al.
Published: (2024-02-01) -
Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests
by: Bryan C Tieman, et al.
Published: (2022-09-01) -
Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents
by: Prabir Kumar Kulabhusan, et al.
Published: (2020-07-01) -
Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients
by: Xihong Zhang, et al.
Published: (2023-06-01)